Market Tracker

12/02 5:16pm ET

Zoetis Inc (NYSE:ZTS)

49.10
Delayed Data
As of Dec 02
 -0.06 / -0.12%
Today’s Change
38.26
Today|||52-Week Range
53.14
+2.46%
Year-to-Date
Top Research Reports for Broadcom, PNC Financial & ConocoPhillips
Dec 01 / Zacks.com - Paid Partner Content
3 Top Recession-Proof Stocks to Buy
Nov 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close49.16
Today’s open49.32
Day’s range48.55 - 49.36
Volume3,183,437
Average volume (3 months)3,616,356
Market cap$24.3B
Dividend yield0.77%
Data as of 4:04pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+9.64%
Earnings growth (next 5 years)+12.87%
Revenue growth (last year)-0.42%
P/E ratio35.3
Price/Sales5.05
Price/Book22.90

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.38+0.87%
ALXNAlexion Pharmaceutic...+0.95+0.78%
VRTXVertex Pharmaceutica...-2.32-2.98%
MYLMylan NV-0.04-0.11%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)$0.45
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts